What's Hot

    M&G agrees two bulk purchase annuity deals totalling $760m

    21 September 2023

    ELSA Welcomes New Executive Board Members

    19 September 2023

    Editor’s Letter – Volume 2, Issue 9, September 2023

    15 September 2023
    Facebook Twitter Instagram
    Instagram LinkedIn Twitter
    Life Risk News
    • Home
    • Features

      Spotlight Falls on US Life Insurers’ Private Debt Investments

      14 September 2023

      The US Now The Last Remaining Traded Life Policy Market

      14 September 2023

      Re-Visiting the SEC Life Settlements Task Force More Than a Decade Later

      14 September 2023

      Generative AI Set to Transform Life Insurance Industry

      14 September 2023

      Q&A: David Blake, Professor of Finance & Director of Pensions Institute, Bayes Business School

      14 September 2023
    • Commentary

      The Critical Nature of Life Insurance Policy Due Diligence in the Life Settlement Asset Class

      14 September 2023

      Covid-19 Excess Mortality Analysis

      14 September 2023

      The Insurance Regulator Takes a Look at Funded Reinsurance

      10 August 2023

      Life Settlement Apocrypha

      10 August 2023

      UK Closed Life Funds – A Secret Returns Goldmine?

      12 July 2023
    • Events
    • Magazine
    • News

      M&G agrees two bulk purchase annuity deals totalling $760m

      21 September 2023

      ELSA Welcomes New Executive Board Members

      19 September 2023

      Prudential Financial and Warburg Pincus back new annuity reinsurer

      14 September 2023

      Ford UK pension scheme signs $450m partial buy-in deal

      14 September 2023

      European Life Settlement Association (ELSA) Hosts Successful Secondary Life Markets Conference 2023

      13 September 2023
    Subscribe
    Life Risk News
    Home»Commentary»If Longevity Risk is an Asset Class, How Do We Make It More Tradeable?

    If Longevity Risk is an Asset Class, How Do We Make It More Tradeable?

    Commentary 13 July 2022Erik PickettBy Erik Pickett
    Twitter LinkedIn Email
    Longevity Risk
    Share
    Twitter LinkedIn Email

    Over the years, we have witnessed the successful commoditisation of several risks, including credit risk, interest rate risk and property catastrophe risk, opening up their trade to capital markets investors. Similar commoditisation of longevity risk has been slow to take off, despite many seeing a significant need for more risk takers in the market to boost capacity to service the world-wide c$80tr of longevity-linked liabilities.

    During May’s ELSA Life ILS conference, Jennifer Haid, CEO of Club Vita hosted an expert discussion with Joyeeta Kanungo (Phoenix), Stephen Richards (Longevitas), Scott Willkomm (Life Equity) and Phil Kane (Leadenhall Capital) on the current outlook for a commoditised longevity risk market. Here are some key learnings from this session.

    What is longevity / life risk?

    Longevity risk is the risk that people live longer lives than expected. Any institution guaranteeing lifetime payments is exposed to adverse longevity risk. This includes defined benefit pension funds, life insurers, reinsurers, and government social security systems. Life insurers are also exposed to the opposite risk of policyholders dying sooner than their expected. Collectively, this pair of opposing risks is called “life risk”.

    As part of an effective risk management strategy, the originator of a risk will often look to transfer it to a party better suited to handle it. This risk taker, may itself then look to pass on all or some of this risk. This process, known as the risk transfer chain, can continue and should result in risk ultimately ending up in institutions that are better equipped to manage it. But the more market frictions, the more inefficient the risk transfer chain becomes. Currently, in almost all cases, each step of the longevity risk transfer chain is underpinned by full indemnity contracts, tracking the survival of a named group of people. This means risk cedants are relieved of their complete profile of longevity risk, but risk takers take on highly specific long-term contracts that are difficult to trade.

    What do we mean by the commoditisation of longevity risk and what are its benefits?

    The commoditisation of longevity risk is the development of fungible, tradable financial instruments linked to longevity risk that increase the efficiency of each step of the risk transfer chain and ultimately the creation of a deep liquid market for longevity risk. Commoditisation should attract more, much needed, capacity in longevity risk takers. This is expected largely to come from capital markets investors entering the market, attracted by returns diversified against key financial risks, with some extra capacity also released from existing players due to standardisation and automation.

    It is often not economical for small pension funds to enter into complicated indemnity contracts to remove longevity risk. Streamlining of contracts such as those implemented by Mercer and Zurich have opened up this market to smaller players to a certain extent, but complete commoditisation would open it up further. By simplifying the process and increasing the supply of risk takers, commoditisation should create competitive pricing for longevity risk transfers. The clearing price will of course be affected by any increase in demand, but price loadings due to market frictions should be reduced; a commoditised market could allow risks that have not traditionally attracted insurers or reinsurers, such as deferred annuity longevity risk contracts. A standardised risk classification system and index-based instruments will enable more efficient risk management solutions, in particular allowing more efficient balancing of longevity and mortality risk and reducing capital demands.

    Why hasn’t it happened (yet) and what needs to happen to develop this market?

    Commoditisation is based around insuring longevity trend risk and results in some components of risk being left with the risk cedant. Cedants may prefer to transfer all their risk, especially as current market prices are perceived as low. The capacity of risk takers has so far been sufficient for the risk cedants coming to market – only a small percentage of world-wide longevity-linked liabilities have transferred into global reinsurance regimes.

    There is no fixed precedent for the capital relief available to insurers when using commoditised structures to pass on their longevity trend risk. Insurers want to ensure they receive the capital relief they deserve in the event of insuring risks; investors have been put off by the length of term in traditional run off longevity hedges. To dates there has been no wide acceptance of a standardised model, index or terms on which to trade commoditised longevity.

    For a commoditised market to develop, there needs to be a standardisation of terms for the writing of financial instruments. Central to that will be the development of a set of widely accepted and accessible reference indices that would mimic the movements on the risk cedants’ balance sheets. Index-linked instruments would be highly tradable and could protect cedants from extreme outcomes; they would also allow risk traders to act on their sentiment to future longevity risk. Innovative approaches to structuring financial instruments need to be developed that are attractive to both risk cedants and risk takers, in particular, instruments that reduce the time horizon of traditional indemnity swaps (such as those using commutation mechanisms) are needed to attract capital market investors. Shrinking the margins of dealers in a commoditised market could help to increase returns. Articulating the potential capital benefits of pairing longevity and mortality risk, or the diversification effect of longevity with key financial risks could help engage investors with the potential returns.

    In the event of a capacity crunch in the conventional longevity market, the cost of protection could rise, offering higher returns for capital market investors. If governments could provide some back up liquidity in the market as they do in some secondary mortgage markets, it may encourage more risk takers to enter the market and ultimately strengthen the whole eco-system. Confirmation of regulatory capital relief obtained from any new financial instruments must be confirmed before they will become attractive to institutions governed by those capital requirements.

    Why is now any different?

    Despite some previous false starts for the commoditised longevity market, it feels like the stars may finally be aligning. Over the last few years there has been real concern in the reinsurance community about a capacity crunch if the projected annual market demand materialises. Pension fund consolidators and the success of streamlined longevity swap contracts are bringing smaller pension funds into the de-risking market and new ideas about structuring financial instruments to address the key obstacle of shorter term contracts have now been developed. Players in the market such as Longitude Exchange and Club Vita are working to standardise models and index data to get everyone talking the same language.

    For a market to develop, timing of many factors need to align. Maybe that is what’s happening right now.

    Erik Pickett PhD FIA CERA, is Actuary & Chief Content Officer at Club Vita

    Volume 1 Issue 3 - July 2022
    Share. Twitter LinkedIn Email

    Related Posts

    The Critical Nature of Life Insurance Policy Due Diligence in the Life Settlement Asset Class

    14 September 2023

    Covid-19 Excess Mortality Analysis

    14 September 2023

    The Insurance Regulator Takes a Look at Funded Reinsurance

    10 August 2023

    Life Settlement Apocrypha

    10 August 2023

    Comments are closed.

    Most Popular

    Spotlight Falls on US Life Insurers’ Private Debt Investments

    14 September 2023

    The US Now The Last Remaining Traded Life Policy Market

    14 September 2023

    Re-Visiting the SEC Life Settlements Task Force More Than a Decade Later

    14 September 2023

    Generative AI Set to Transform Life Insurance Industry

    14 September 2023
    Ad

    Your trusted source for capital markets participation in Life Risk

    Twitter Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT